Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1234.60
-10.90 (-0.88%) Dr. Reddy’s Laboratories informs about press release
Date: 09-12-2021Dr. Reddy’s Laboratories has informed that it enclosed a Press Release on December 09,2021 titled ‘Prestige BioPharma and Dr. Reddy’s announce partnership to commercialize trastuzumab biosimilar in select countries in Latin America and Southeast Asia’.
The above information is a part of company’s filings submitted to BSE.